Acceleron Pharma (XLRN) PT Raised to $171 at Citi
Tweet
Share
E-mailGet Alerts XLRN Hot Sheet
Price: $122.05 --0%
Rating Summary:
17 Buy, 4 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 7 | New: 42
Rating Summary:
17 Buy, 4 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 7 | New: 42
Trade Now!
Join SI Premium – FREE
Citi analyst Yigal Nochomovitz raised the price target on Acceleron Pharma (NASDAQ: XLRN) to $171.00 (from $137.00) while maintaining a Buy rating.
You May Also Be Interested In
- UPDATE: Citi Upgrades First Solar (FSLR) to Buy, 'Catalyst Rich Environment'
- UBS Downgrades Purplebricks Group (PURP:LN) (PRPPF) to Sell
- Brenntag AG (BNR:GR) (BNTGY) PT Raised to EUR90 at HSBC
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
